The Future of Presbyopia Drops - Summary - MDSpire

The Future of Presbyopia Drops

An update on the expanding category of topical drugs to treat presbyopia.

  • By

  • Jennifer Ponte Canning, Managing Editor

  • April 1, 2025

  • 8 min

Share

Objective:

To provide an update on the expanding category of FDA-approved eye drops for the treatment of presbyopia.

Key Findings:
  • Ensure findings are directly linked to the source material.
Interpretation:

The presbyopia treatment landscape is evolving with multiple new formulations showing potential benefits, indicating a growing market for non-surgical options.

Limitations:
  • Specify age-related limitations in the context of treatment suitability.
Conclusion:

The future of presbyopia drops looks promising with ongoing developments and approvals, potentially offering improved options for patients.

Original Source(s)

The Future of Presbyopia Drops

  • by Jennifer Ponte Canning, Managing Editor

  • April 1, 2025

Related Content

A Year of First Endeavors

An introduction to the October 2025 Dry Eye Disease issue by Jane T. Shuman, Editor in Chief.

Refining Our Approaches to Cataract and Refractive Surgery

Our April issue arrives ahead of the American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting and reflects the dynamic and ever-evolving landscape of refractive and cataract surgery.

Scaling Vision Innovation

Rob Scott, Vice President of Intraocular Devices R&D, Alcon

  • March 16, 2026

  • 3 min